Advertisement

Antibiotic Prophylaxis and Infectious Complications in PNL

  • Oscar R. Negrete-PulidoEmail author
  • Jorge Gutiérrez-Aceves
Chapter

Abstract

Postoperative infection in PNL represents one of the most feared and life-threatening complications in current urologic practice. In this chapter the importance of a correct preoperative evaluation of the patient and of the related risk factors is described; adequate antibiotic prophylaxis and intraoperative measures to prevent the development of infectious adverse events are indicated; early postoperative signs that could anticipate the development of a sepsis, in order to achieve a timely diagnosis and establish early measures that consequently will reduce morbidity and mortality, are identified. These are the basic principles and key points that will help us to perform a secure PNL, limiting intraoperative risk.

Keywords

Systemic Inflammatory Response Syndrome Infectious Complication Urine Culture Drotrecogin Alfa Nephrostomy Tube 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Skolarikos A, Alivizatos G, de la Rosette JJ (2005) Percutaneous nephrolithotomy and its legacy. Eur Urol 47:22–28PubMedCrossRefGoogle Scholar
  2. 2.
    Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899–906PubMedCrossRefGoogle Scholar
  3. 3.
    Skolarikos A, de la Rosette J (2008) Prevention and treatment of complications following percutaneous nephrolithotomy. Curr Opin Urol 18:229–234PubMedCrossRefGoogle Scholar
  4. 4.
    O’Keefe NK, Mortimer AJ, Sambrook PA, Rao PN (1993) Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol 72:277–283Google Scholar
  5. 5.
    Rao PN, Dube DA, Weightman NC et al (1991) Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 146:955–960PubMedGoogle Scholar
  6. 6.
    Gutierrez J, Smith A, Geaylete P et al (2012) On behalf of the CROES PCNL Study Group Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol. doi: 10.1007/s00345-012-0836-y PubMedGoogle Scholar
  7. 7.
    Draga RO, Kok ET, Sorel MR et al (2009) Percutaneous nephrolithotomy: factors associated with fever after the first postoperative day and systemic inflammatory response syndrome. J Endourol 23:921–927PubMedCrossRefGoogle Scholar
  8. 8.
    Bichler KH, Elipper E, Naber K et al (2002) Urinary infection stones. Int J Antimicrob Agents 19:488–498PubMedCrossRefGoogle Scholar
  9. 9.
    Neal DE Jr (2008) Complicated urinary tract infections. Urol Clin North Am 35:13–22PubMedCrossRefGoogle Scholar
  10. 10.
    Beutler B (2004) Inferences, questions and possibilities in toll like receptor signaling. Nature 430:257–263PubMedCrossRefGoogle Scholar
  11. 11.
    Wagenlehner FM, Weidner W, Naber KG (2007) Optimal management of urosepsis from the urological perspective. Int J Antimicrob Agents 30:390–397PubMedCrossRefGoogle Scholar
  12. 12.
    Nguyen B, Rivers E, Abrahamian F et al (2006) Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 48:28–54PubMedGoogle Scholar
  13. 13.
    Hofmann W (1990) Urosepsis and uroseptic shock. Z Urol Nephrol 83:317–324PubMedGoogle Scholar
  14. 14.
    Foz A (1976) Sepsis of urological origin: microbiological aspects. Antibiot Chemother 21:69–72PubMedGoogle Scholar
  15. 15.
    DasGupta R, Sullivan R, French G, O’Brien TS (2009) Evidence based prescription of antibiotics in urology: a 5-year review of microbiology. BJU Int 104:760–764PubMedCrossRefGoogle Scholar
  16. 16.
    Thiruchelvam N, Yeoh SL, Keoghan SR (2006) MRSA in urology: a UK hospital experience. Eur Urol 49:896–899PubMedCrossRefGoogle Scholar
  17. 17.
    DasGupta R, French G, Glass JM (2008) Multi-resistant Pseudomonas aeruginosa outbreak in an endourology unit. Eur Urol 53:1009CrossRefGoogle Scholar
  18. 18.
    Kashanian J, Hakimian P, Blute M Jr et al (2008) Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int 102:1634–1637PubMedCrossRefGoogle Scholar
  19. 19.
    Matlaga B, Kim S, Lingeman J (2005) Improving outcomes in percutaneous nephrolithotomy: access. EAU Update Series 3:37–43CrossRefGoogle Scholar
  20. 20.
    Book M, Lehmann LE, Schewe JC, Weber S (2005) Urosepsis. current therapy and diagnosis. Urologe A 44:413–422PubMedCrossRefGoogle Scholar
  21. 21.
    Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A (2008) Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 54:1270–1286PubMedCrossRefGoogle Scholar
  22. 22.
    Bratzler DW, Houck PM (2005) Surgical infection prevention guideline writers. Workgroup: antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 189:395–404PubMedCrossRefGoogle Scholar
  23. 23.
    Charton M, Vallancien G, Veillon B, Brisset JM (1986) Urinary tract infection in percutaneous surgery for renal calculi. J Urol 135:15–17PubMedGoogle Scholar
  24. 24.
    Darenkov AF, Derevianko II, Martov AG et al (1994) The prevention of infectious-inflammatory complications in the postoperative period in percutaneous surgical interventions in patients with urolithiasis. Urol Nephrol 2:24–26Google Scholar
  25. 25.
    Mariappan P, Smith G, Moussa SA, Tolley DA (2006) One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int 98:1075–1079PubMedCrossRefGoogle Scholar
  26. 26.
    Mariappan P, Smith G, Bariol SV et al (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610–1614PubMedCrossRefGoogle Scholar
  27. 27.
    Seyrek M, Binbay M, Yuruk E et al (2012) Perioperative prophylaxis for percutaneous nephrolithotomy: randomized study concerning the drug and dosage. J Endourol 26:1431–1436PubMedCrossRefGoogle Scholar
  28. 28.
    Dogan HS, Sahin A, Cetinkaya Y et al (2002) Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol 16:649–653PubMedCrossRefGoogle Scholar
  29. 29.
    Kumar S, Bag S, Ganesamoni R et al (2012) Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis. Urol Res 40:79–86PubMedCrossRefGoogle Scholar
  30. 30.
    Wolf JS Jr, Bennett CJ, Dmochowski RR, Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel et al (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379–1390PubMedCrossRefGoogle Scholar
  31. 31.
    Grabe M, Bishop MC, Bjerklund-Johansen TE et al (2009) European Association of Urology. Guidelines on urological infections. European Guidelines Office Publications. Available at www.uroweb.org/guidelines
  32. 32.
    Margel D, Ehrlich Y, Brown N et al (2006) Clinical implication of routine stone culture in percutaneous nephrolithotomy – a prospective study. Urology 67:26–29PubMedCrossRefGoogle Scholar
  33. 33.
    Dogan HS, Guliyev F, Ceinkaya YS et al (2007) Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol 39:737–742PubMedCrossRefGoogle Scholar
  34. 34.
    Lojanapiwat B (2011) Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy. Urol Int 86:448–452PubMedCrossRefGoogle Scholar
  35. 35.
    McAleer IM, Kaplan GW, Bradley JS et al (2003) Endotoxin content in the renal calculi. J Urol 169:1813–1814PubMedCrossRefGoogle Scholar
  36. 36.
    Prabakharan S, Teichman J, Spore SS et al (1999) Proteus mirabilis viability after lithotripsy of struvite calculi. J Urol 162:1666–1669PubMedCrossRefGoogle Scholar
  37. 37.
    Quintero MS, Alvarez UM, Wacher C et al (2008) Interaction of shock waves with infected kidney stones: is there a bactericidal effect? J Endourol 22:1629–1638CrossRefGoogle Scholar
  38. 38.
    Gómez-Núñez JG, Alvarez UM, Fernández F et al (2009) Interaction of intracorporeal lithotripters with Proteus mirabilis inoculated inside artificial calcium and struvite stones. J Endourol 23:519–522PubMedCrossRefGoogle Scholar
  39. 39.
    Gutiérrez J, Alvarez UM, Mues E et al (2008) Inactivation of bacteria inoculated inside urinary stones-phantoms using intracorporeal lithotripters. Urol Res 36:67–72PubMedCrossRefGoogle Scholar
  40. 40.
    Troxel SA, Low RK (2002) Renal intrapelvic pressure during percutaneous nephrolithotomy and its correlation with the development of postoperative fever. J Urol 168:1348–1351PubMedCrossRefGoogle Scholar
  41. 41.
    Zhong W, Zeng G, Wu K et al (2008) Does a smaller tract in percutaneous nephrolithotomy contribute to high renal pelvic pressure and postoperative fever? J Endourol 22:2147–2151PubMedCrossRefGoogle Scholar
  42. 42.
    Ramsay S, Robertson A, Ablett MJ et al (2010) Evidence-based drainage of infected hydronephrosis secondary to ureteric calculi. J Endourol 24:185–189CrossRefGoogle Scholar
  43. 43.
    Mokhmalji H, Braun M, Martinez-Portillo FJ et al (2001) Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: A prospective, randomized clinical trial. J Urol 165:1088–1092PubMedCrossRefGoogle Scholar
  44. 44.
    Aron M, Goel R, Gupta NP, Seth A (2005) Incidental detection of purulent fluid in kidney at percutaneous nephrolithotomy for branched renal calculi. J Endourol 19:136–139PubMedCrossRefGoogle Scholar
  45. 45.
    Hosseini MM, Basiri A, Moghadamm SM (2007) Percutaneous nephrolithotomy of patients with staghorn stone and incidental purulent fluid suggestive of infection. J Endourol 21:1429–1432PubMedCrossRefGoogle Scholar
  46. 46.
    Cadeddu JA, Chen R, Bishoff J et al (1998) Clinical significance of fever after percutaneous nephrolithotomy. Urology 52:48–50PubMedCrossRefGoogle Scholar
  47. 47.
    Ziaee SA, Kazemi B, Moghaddam SM et al (2008) A study of febrile versus afebrile patients after percutaneous nephrolithotomy regarding bacterial etiologic factors through blood and urine cultures and 16S rRNA detection in serum. J Endourol 22:2717–2721PubMedCrossRefGoogle Scholar
  48. 48.
    Uzzan B, Cohen R, Nicolas P et al (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34:1996–2003PubMedCrossRefGoogle Scholar
  49. 49.
    Negrete-Pulido O, Gutiérrez-Aceves J (2009) Management of infectious complications in percutaneous nephrolithotomy. J Endourol 23:1–6CrossRefGoogle Scholar
  50. 50.
    Sihler KC, Nathens AB (2006) Management of severe sepsis in the surgical patient. Surg Clin North Am 86:1457–1481PubMedCrossRefGoogle Scholar
  51. 51.
    Gilbert DN, Moellering R, Eliopoulos GM, Sande MA (eds) (2008) The Sanford guide to antimicrobial therapy, 38th edn. Sanford Guide, SperryvilleGoogle Scholar

Copyright information

© Springer-Verlag France 2014

Authors and Affiliations

  • Oscar R. Negrete-Pulido
    • 1
    Email author
  • Jorge Gutiérrez-Aceves
    • 2
  1. 1.Department of Urology, Lithiasis and Endourology Clinic, UrologyHospital Ángeles LEÓN, Hospital Regional de Alta Especialidad del BajíoLeónMexico
  2. 2.Department of UrologyWake Forest School of Medicine, Medical Center BoulevardWinston-SalemUSA

Personalised recommendations